FreeStyle LibreLink
-
4.6
-
Developer
Abbott Diabetes Care Inc.
-
Category
Medical
-
Version
2.8.2
-
Android OS
Varies with device
-
Downloads
600M
-
Content rating
0
Pro
👍 FreeStyle LibreLink lets you scan a FreeStyle Libre sensor with a compatible iPhone or Android phone to get instant glucose readings and trend arrows. The quick, on-demand checks simplify monitoring and reduce manual recordkeeping, fitting seamlessly into daily routines without requiring a separate dedicated reader.
👍 Built-in trend graphs, pattern analysis, and downloadable reports make it easy to spot highs, lows, and time-in-range trends. Clear visual summaries, including daily and weekly breakdowns, can be shared with your healthcare team via LibreView, helping guide therapy adjustments and track progress between clinic visits.
👍 When paired with FreeStyle Libre 2 sensors, the app offers optional customizable high/low glucose alarms and on-phone notifications. Users can securely share real-time data with caregivers and clinicians through LibreLinkUp and LibreView, enabling faster responses to glucose events and coordinated remote support for better day-to-day management.
Con
👎 Requires specific device and sensor compatibility. FreeStyle LibreLink only works with Abbott FreeStyle Libre sensors and supports a limited list of smartphones and OS versions; older phones, unsupported Android/iOS builds, or devices without NFC/Bluetooth may not be able to use the app, creating setup headaches for some users.
👎 Real-time monitoring and alerts are limited compared with continuous-streaming CGMs. Depending on the sensor model, the app can rely on manual scans or offer only basic alarms, and true continuous live data streaming or seamless remote monitoring isn’t as robust as competing platforms, which can reduce timely detection of rapid glucose changes.
👎 Sensor readings can sometimes differ from fingerstick blood-glucose values, especially during rapid glucose shifts. The app’s data and alerts aren’t a substitute for confirmatory meter checks when making treatment decisions. Users also report occasional sync or data-export limitations and less advanced analytics than dedicated diabetes management software.
Screenshots
